Insulin market in the US and Europe to cross over $26 billion in revenues through 2020
This market research analysis presents a detailed segmentation of the insulin market in the US and Europe by drug class (fast-acting, intermediate-acting, and long-acting), by application (type 1 and type 2 diabetes), by delivery technologies (injectable insulin, insulin pumps, oral insulin, inhaled insulin, and others), and by geography (Europe and the US). Key vendors…